STOCK TITAN

RYTHM, Inc. 8-K Filings

RYM NASDAQ

Every 8-K that RYTHM, Inc. (RYM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow RYM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RYM filings page.

Rhea-AI Summary

Rythm, Inc. entered into an amendment with RSLGH, LLC and Vision Management Services, LLC that removes all beneficial ownership limitations on the conversion of secured convertible notes, the exercise of pre-funded warrants, and certain future pre-funded warrants under a shared services agreement. The amendment, effective October 10, 2026, applies to notes with an aggregate original principal amount of $72.0 million and pre-funded warrants to purchase up to 9,731,638 common shares.

As a result of removing these limits, RSLGH’s beneficial ownership of Rythm common stock increased from 49.99% to approximately 89.9% as of August 11, 2026, constituting a change in control. As of August 10, 2026, there were 2,179,128 common shares outstanding, including 698,961 held by RSLGH, acquired for aggregate consideration of $109.5 million funded from Green Thumb working capital, note interest, and shared-services fees. The related securities were issued in private placements relying on Section 4(a)(2) and Rule 506(b), and shareholders approved the required share issuances under Nasdaq Listing Rule 5635 with 1,118,058 votes in favor.

Rhea-AI Summary

RYTHM, Inc. reported a record second quarter for the period ended June 30, 2026. Revenue was $23,021k (amounts in thousands of U.S. dollars), with management noting 73% sequential growth, exceeding prior guidance of 65%. Gross profit reached $18,536k, producing operating income from continuing operations of $1,936k and income from continuing operations of $1,184k, or $0.09 per diluted share. Adjusted EBITDA was $6,357k, compared with a loss a year earlier.

For the first half of 2026, revenue totaled $36,307k and net income $21,106k. Operating cash flow was positive at $9,697k, and the balance sheet showed cash of $41,915k against current related-party debt of $72,000k and total equity of $39,087k. Management highlighted accelerating demand for THC beverages, expanded partnerships with venues such as Lollapalooza and Opry Entertainment Group, and reiterated confidence in the category while cautioning that pending federal restrictions on hemp-derived THC products, effective November 2026, create regulatory uncertainty.

Rhea-AI Summary

RYTHM, Inc. reported results of its 2026 annual stockholder meeting, where stockholders approved an amendment to the 2022 Omnibus Equity Incentive Plan to increase the shares available for equity awards by 115,000. All seven director nominees were elected for one-year terms continuing until the 2027 meeting or until successors are elected and qualified. Stockholders also ratified the appointment of GuzmanGray as independent registered public accounting firm for the year ending December 31, 2026. At the meeting, 1,560,696 shares out of 2,149,128 issued and outstanding as of April 20, 2026 were represented, representing approximately 72.61% of eligible shares and constituting a quorum.

Rhea-AI Summary

RYTHM, Inc. reported strong top-line growth for the first quarter of 2026, with revenue rising to $13,286 thousand from $538 thousand a year earlier. Gross profit reached $10,397 thousand on significantly higher sales.

The company posted net income from continuing operations of $19,922 thousand, driven largely by an income tax benefit of $25,593 thousand. On an operating basis, RYTHM recorded an EBITDA loss of $486 thousand and Adjusted EBITDA of $(21) thousand, nearly breakeven.

RYTHM ended March 31, 2026 with $33,261 thousand in cash and cash equivalents and generated $1,043 thousand of cash from operating activities in the quarter. Management highlighted 24% sequential revenue growth, a 78% gross margin, and brand leadership across key THC categories, while noting regulatory uncertainty around a potential federal hemp ban.

Rhea-AI Summary

RYTHM, Inc. amended two trademark and recipe license agreements with Green Thumb Industries’ subsidiary GTI Core. Effective April 1, 2026, GTI Core will pay an annual cash fee of $64.0 million for brands including RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, &Shine and Good Green, replacing a sales-based royalty, with CPI-linked increases capped at 10% per year.

For the incredibles brand, GTI Core will pay an additional fixed annual cash fee of $6.0 million, also CPI-linked with a 10% cap. A company press release states these changes result in an aggregate fixed annual cash fee of $70 million from Green Thumb and were made following discussions with Nasdaq staff to support compliance with Nasdaq Capital Market listing standards related to revenue from the federally illegal cannabis industry.

Rhea-AI Summary

RYTHM, Inc. reported rapid growth in hemp-derived THC brands alongside continued losses for the quarter and year ended December 31, 2025. Full-year revenue rose to $17,283 thousand from $18 thousand in 2024, while net loss narrowed to $33,257 thousand from $41,746 thousand.

In the fourth quarter, revenue reached $10,660 thousand, and the company highlighted licensing revenue of $7.0 million contributing to an approximate 75% gross margin. Weighted average shares outstanding nearly doubled year over year, reflecting a larger equity base.

RYTHM ended 2025 with $32,218 thousand of cash and total assets of $106,677 thousand, offset by significant related party and other debt. Net cash used in operating and investing activities was more than covered by financing inflows, resulting in a modest cash increase.